175 related articles for article (PubMed ID: 32951125)
1. Distinguishing pheochromocytoma from adrenal adenoma by using modified computed tomography criteria.
Kang S; Oh YL; Park SY
Abdom Radiol (NY); 2021 Mar; 46(3):1082-1090. PubMed ID: 32951125
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Quantitative MRI and CT Washout Analysis for Differentiation of Adrenal Pheochromocytoma From Adrenal Adenoma.
Schieda N; Alrashed A; Flood TA; Samji K; Shabana W; McInnes MD
AJR Am J Roentgenol; 2016 Jun; 206(6):1141-8. PubMed ID: 27011100
[TBL] [Abstract][Full Text] [Related]
3. Adrenal Adenoma and Pheochromocytoma: Comparison of Multidetector CT Venous Enhancement Levels and Washout Characteristics.
Northcutt BG; Trakhtenbroit MA; Gomez EN; Fishman EK; Johnson PT
J Comput Assist Tomogr; 2016; 40(2):194-200. PubMed ID: 26978001
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic performance of adrenal CT in the differentiation of adenoma and pheochromocytoma.
Altinmakas E; Perrier ND; Grubbs EG; Lee JE; Prieto VG; Ng CS
Acta Radiol; 2020 Aug; 61(8):1080-1086. PubMed ID: 31791129
[TBL] [Abstract][Full Text] [Related]
5. Inter-method agreement between wash-in and wash-out computed tomography for characterizing hyperattenuating adrenal lesions as adenomas or non-adenomas.
Kim MJ; Kang KA; Kim CK; Park SY
Eur Radiol; 2023 Mar; 33(3):2218-2226. PubMed ID: 36173446
[TBL] [Abstract][Full Text] [Related]
6. Inter-individual comparison of diagnostic accuracy of adrenal washout CT compared to chemical shift MRI plus the T2-weighted (T2W) adrenal MRI calculator in indeterminate adrenal masses: a retrospective non-inferiority study.
McPhedran R; Gerson R; Alfaleh H; Sathiadoss P; Schieda N
Abdom Radiol (NY); 2022 Jul; 47(7):2453-2461. PubMed ID: 35536326
[TBL] [Abstract][Full Text] [Related]
7. Pheochromocytoma as a frequent false-positive in adrenal washout CT: A systematic review and meta-analysis.
Woo S; Suh CH; Kim SY; Cho JY; Kim SH
Eur Radiol; 2018 Mar; 28(3):1027-1036. PubMed ID: 29026974
[TBL] [Abstract][Full Text] [Related]
8. MDCT of adrenal masses: Can dual-phase enhancement patterns be used to differentiate adenoma and pheochromocytoma?
Northcutt BG; Raman SP; Long C; Oshmyansky AR; Siegelman SS; Fishman EK; Johnson PT
AJR Am J Roentgenol; 2013 Oct; 201(4):834-9. PubMed ID: 24059372
[TBL] [Abstract][Full Text] [Related]
9. Pheochromocytomas Versus Adenoma: Role of Venous Phase CT Enhancement.
Mohammed MF; ElBanna KY; Ferguson D; Harris A; Khosa F
AJR Am J Roentgenol; 2018 May; 210(5):1073-1078. PubMed ID: 29570377
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of adrenal adenoma and nonadenoma in unenhanced CT: new optimal threshold value and the usefulness of size criteria for differentiation.
Park SH; Kim MJ; Kim JH; Lim JS; Kim KW
Korean J Radiol; 2007; 8(4):328-35. PubMed ID: 17673844
[TBL] [Abstract][Full Text] [Related]
11. Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT.
Szolar DH; Korobkin M; Reittner P; Berghold A; Bauernhofer T; Trummer H; Schoellnast H; Preidler KW; Samonigg H
Radiology; 2005 Feb; 234(2):479-85. PubMed ID: 15671003
[TBL] [Abstract][Full Text] [Related]
12. Can established CT attenuation and washout criteria for adrenal adenoma accurately exclude pheochromocytoma?
Patel J; Davenport MS; Cohan RH; Caoili EM
AJR Am J Roentgenol; 2013 Jul; 201(1):122-7. PubMed ID: 23789665
[TBL] [Abstract][Full Text] [Related]
13. Low-density pheochromocytoma on CT: a mimicker of adrenal adenoma.
Blake MA; Krishnamoorthy SK; Boland GW; Sweeney AT; Pitman MB; Harisinghani M; Mueller PR; Hahn PF
AJR Am J Roentgenol; 2003 Dec; 181(6):1663-8. PubMed ID: 14627592
[TBL] [Abstract][Full Text] [Related]
14. Hyperattenuating adrenal lesions in lung cancer: biphasic CT with unenhanced and 1-min enhanced images reliably predicts benign lesions.
Lee HY; Oh YL; Park SY
Eur Radiol; 2021 Aug; 31(8):5948-5958. PubMed ID: 33459853
[TBL] [Abstract][Full Text] [Related]
15. Accuracy of focal cystic appearance within adrenal nodules on contrast-enhanced CT to distinguish pheochromocytoma and malignant adrenal tumors from adenomas.
Corwin MT; Mitchell AS; Wilson M; Campbell MJ; Fananapazir G; Loehfelm TW
Abdom Radiol (NY); 2021 Jun; 46(6):2683-2689. PubMed ID: 33415383
[TBL] [Abstract][Full Text] [Related]
16. CT sensitivity for adrenal adenoma according to lesion size.
Park SY; Park BK; Park JJ; Kim CK
Abdom Imaging; 2015 Oct; 40(8):3152-60. PubMed ID: 26254908
[TBL] [Abstract][Full Text] [Related]
17. Validation of the modified CT criteria for identifying non-adenomas.
Kwak MH; Yun JS; Kim JN; Lee YR; Kim CK; Kang KA
Abdom Radiol (NY); 2024 May; 49(5):1603-1614. PubMed ID: 38411694
[TBL] [Abstract][Full Text] [Related]
18. The value of 15-minute delayed contrast-enhanced CT to differentiate hyperattenuating adrenal masses compared with chemical shift MR imaging.
Koo HJ; Choi HJ; Kim HJ; Kim SO; Cho KS
Eur Radiol; 2014 Jun; 24(6):1410-20. PubMed ID: 24647823
[TBL] [Abstract][Full Text] [Related]
19. Adenoma characterization: adrenal protocol with dual-energy CT.
Kim YK; Park BK; Kim CK; Park SY
Radiology; 2013 Apr; 267(1):155-63. PubMed ID: 23329655
[TBL] [Abstract][Full Text] [Related]
20. Unenhanced CT imaging is highly sensitive to exclude pheochromocytoma: a multicenter study.
Buitenwerf E; Korteweg T; Visser A; Haag CMSC; Feelders RA; Timmers HJLM; Canu L; Haak HR; Bisschop PHLT; Eekhoff EMW; Corssmit EPM; Krak NC; Rasenberg E; van den Bergh J; Stoker J; Greuter MJW; Dullaart RPF; Links TP; Kerstens MN
Eur J Endocrinol; 2018 May; 178(5):431-437. PubMed ID: 29467230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
